Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: JACC: Cardiovascular Interventions - Volume 10, Issue 8, 24 April 2017, Pages 774-782

Suzanne J. MD, MSc, Yang MS, Khaja MS, Katherine MS, Elizabeth A. ScD, Dean J. MD, Stephen G. MD, Gregg W. MD, David J. MD, MSc, ABSORB III Investigators ABSORB III Investigators,